Health Sciences Acquisitions Corporation 2
40 10th Avenue, Floor 7
New York, NY 10014
December 15, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
| Attn: | Doris Stacey Gama |
| Dorrie Yale |
| RE: | Health Sciences Acquisitions Corporation 2 |
| Amendment No. 4 to Registration Statement on Form S-4 | |
| Filed December 13, 2022 | |
| File No. 333-266660 |
Dear Ms. Gama and Ms. Yale:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the registrant, Health Sciences Acquisitions Corporation 2, hereby requests acceleration of effectiveness of the above-referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time on December 16, 2022, or as soon as practicable thereafter.
| Very truly yours, | ||
| HEALTH SCIENCES ACQUISITIONS CORPORATION 2 | ||
| By: | /s/ Roderick Wong | |
| Roderick Wong, MD | ||
| Chief Executive Officer | ||
